Shane Schaffer

Shane Schaffer, co-founder, Chairman, and CEO of Cingulate Therapeutics, helms this Phase 3 clinical-stage biopharmaceutical company from Kansas City, Kansas.

Launched 6 months ago
By subscribing, I agree to Substack’s Terms of Use and acknowledge its Information Collection Notice and Privacy Policy